IS Pharma, the international speciality pharmaceutical company, announced that overall trading continues to be strong, with sales, gross profit and profit after tax in line with the board's expectations for the six months to 30 September 2010. IS Pharma's broker does not have interim forecasts available, but the announcement could be taken to say that the company is on track to deliver on its full year forecasts to March 2011. The lastest broker update puts sales at £14.7 million and pre-tax profit at £2.7 million.

IS Pharma's interim results are to be announced on November 10th.

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here